Ocata Therapeutics Inc fka OCAT

[farviewhill]

Good observation and warning ELLLK,.
Unfortunately some posters don't appreciate this kind of discussion,
but I sure appreciate it.
They seem to want a Yahoo kind of board.

Biotech history has many examples of a promising phase 2 biotech,whose
research potentially seriously challenges some larger entity, so for a variety of reasons from needed operating capital, to management wanting to cash out rich, they just get bought out friendly or otherwise, and the acquiring company often 'buries' the science.
The Roche's and the Pfizer's of the world with billion dollar drugs for wet and dry macular degeneration play hard ball.